Intranasal Immunization with the Influenza A Virus Encoding Truncated NS1 Protein Protects Mice from Heterologous Challenge by Restraining the Inflammatory Response in the Lungs

by Kirill Vasilyev, Anna-Polina Shurygina, Maria Sergeeva, Marina Stukova, Andrej Egorov
Published 2021-03-01

Oncolytic effects of a novel influenza A virus expressing interleukin-15 from the NS reading frame.

by Marijke van Rikxoort, Martin Michaelis, Markus Wolschek, Thomas Muster, Andrej Egorov, Joachim Seipelt, Hans Wilhelm Doerr, Jindrich Cinatl
Published 2012-01-01

Targeting an Oncolytic Influenza A Virus to Tumor Tissue by Elastase

by Irina Kuznetsova, Tobias Arnold, Thomas Aschacher, Cornelia Schwager, Balazs Hegedus, Tamas Garay, Marina Stukova, Maria Pisareva, Stephan Pleschka, Michael Bergmann, Andrej Egorov
Published 2017-12-01

The Potential of Influenza HA-Specific Immunity in Mitigating Lethality of Postinfluenza Pneumococcal Infections

by Miriam Klausberger, Irina A. Leneva, Irina N. Falynskova, Kirill Vasiliev, Alexander V. Poddubikov, Claudia Lindner, Nadezhda P. Kartaschova, Oxana A. Svitich, Marina Stukova, Reingard Grabherr, Andrej Egorov
Published 2019-11-01

Sublingual immunization with a live attenuated influenza a virus lacking the nonstructural protein 1 induces broad protective immunity in mice.

by Hae-Jung Park, Boris Ferko, Young-Ho Byun, Joo-Hye Song, Gye-Yeong Han, Elisabeth Roethl, Andrej Egorov, Thomas Muster, Baiklin Seong, Mi-Na Kweon, Manki Song, Cecil Czerkinsky, Huan H Nguyen
Published 2012-01-01

Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccine.

by Julia Romanova, Brigitte M Krenn, Markus Wolschek, Boris Ferko, Ekaterina Romanovskaja-Romanko, Alexander Morokutti, Anna-Polina Shurygina, Sabine Nakowitsch, Tanja Ruthsatz, Bettina Kiefmann, Ulrich König, Michael Bergmann, Monika Sachet, Shobana Balasingam, Alexander Mann, John Oxford, Martin Slais, Oleg Kiselev, Thomas Muster, Andrej Egorov
Published 2009-06-01

Single HA2 mutation increases the infectivity and immunogenicity of a live attenuated H5N1 intranasal influenza vaccine candidate lacking NS1.

by Brigitte M Krenn, Andrej Egorov, Ekaterina Romanovskaya-Romanko, Markus Wolschek, Sabine Nakowitsch, Tanja Ruthsatz, Bettina Kiefmann, Alexander Morokutti, Johannes Humer, Janina Geiler, Jindrich Cinatl, Martin Michaelis, Nina Wressnigg, Sanda Sturlan, Boris Ferko, Oleg V Batishchev, Andrey V Indenbom, Rong Zhu, Markus Kastner, Peter Hinterdorfer, Oleg Kiselev, Thomas Muster, Julia Romanova
Published 2011-01-01